Developing selective L-Amino Acid Transport 1 (LAT1) inhibitors: A Structure-Activity Relationship overview
Michael Jutabha(Mahidol University), Hitoshi Endou(Kyorin University), Amit Kumar(Sardar Vallabhbhai Patel University of Agriculture & Technology), Vijay Kumar(University of Colorado Anschutz Medical Campus), Koji Oda(Tokyo Metropolitan University), Meagan Holt(University of Colorado Anschutz Medical Campus), Peter J. Rice(East Tennessee State University), Katie Waers(East Tennessee State University), Julia Bautista(University of Colorado Anschutz Medical Campus), Donald S. Backos(University of Colorado Anschutz Medical Campus), Andrew T. Dodson(University of Colorado Anschutz Medical Campus), James R. Fisher(The University of Texas Medical Branch at Galveston), Yoshikatsu Kanai(Open Society), Kunio SAITO(Tanabe Research Laboratories), Naohiko Anzai(Chiba University), Deshae Gehr(University of Colorado Anschutz Medical Campus)
Cited by 11
Related Papers
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
|Science Translational Medicine|2009|438
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience
|Journal of Hepato-Biliary-Pancreatic Surgery|2000|396
Mutations in Glucose Transporter 9 Gene SLC2A9 Cause Renal Hypouricemia
|The American Journal of Human Genetics|2008|386
Intraductal papillary neoplasia of the liver associated with hepatolithiasis
|Hepatology|2001|282
<scp>l</scp>‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth
|Cancer Science|2009|271